시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 트라마돌(Tramadol) 의약품 시장 보고서(2025년)
Tramadol Drug Global Market Report 2025
상품코드 : 1769779
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,371,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,209,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,048,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 트라마돌 의약품 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 주요 동향으로서는 약물 전달 기술의 혁신, 남용 억제형 약제의 도입, 비오피오이드계 약제와의 병용 치료, AI를 활용한 약제 개발, 복약 모니터링 강화를 위한 스마트 포장의 도입 등이 예상됩니다.

정형외과 질환의 유병률 증가는 트라마돌 의약품 시장의 성장을 가속할 것으로 예측됩니다. 예를 들어, 2023년 3월, 영국의 정부 부문인 Office for Health Improvement & Disparities의 보고서에 따르면, 2022년에는 16세 이상의 17.6%가 장기의 근골격계(MSK) 질환을 가지고 있다고 보고해, 2021년 17.0%보다 증가하고 있는 것이 분명해졌습니다.

또한 의료 지출 증가도 트라마돌 의약품 시장 확대를 뒷받침할 것으로 보입니다. 의료 지출은 특정 기간 동안 의료 서비스, 치료 및 건강 관련 자원에 할당된 총 자금을 포함합니다. 인구의 고령화에 따라 의료 서비스, 장기 간호, 노화에 따른 치료에 대한 수요가 높아지고 있으며, 이들은 의료 제도에 대한 재정 부담을 증대시킵니다. 이러한 지출 증가는 트라마돌의 연구, 규제, 사용에 필요한 인프라를 지원함으로써 트라마돌의 입수와 유통을 지원하고 있습니다. 예를 들어, 2025년 4월 미국에 본사를 둔 전문가 단체인 American Medical Association는 2023년 미국 의료 지출이 7.5% 증가하여 총 4조 9,000억 달러, 1인당 14,570달러에 달한다고 보고했습니다. 이러한 이유로 의료 지출 증가는 트라마돌 의약품 시장의 확대에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Tramadol is a prescription opioid medication designed to alleviate moderate to moderately severe pain by altering how the brain and nervous system interpret pain signals. It achieves this effect by binding to opioid receptors and inhibiting the reuptake of serotonin and norepinephrine, thereby amplifying its analgesic properties.

Tramadol is available in various forms, including tablets, capsules, liquids, suspensions, and others. Tramadol tablets are solid-dose forms taken orally and meant to be swallowed whole. The medication is commonly prescribed for therapeutic applications such as pain relief, treatment of anxiety disorders, and postoperative pain management. It can be administered via oral, intravenous, or intramuscular routes. Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, with end users spanning clinics, hospitals, and other healthcare settings.

The tramadol drug market research report is one of a series of new reports from The Business Research Company that provides tramadol drug market statistics, including tramadol drug industry global market size, regional shares, competitors with a tramadol drug market share, detailed tramadol drug market segments, market trends and opportunities, and any further data you may need to thrive in the tramadol drug industry. The tramadol drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tramadol drug market size has grown strongly in recent years. It will grow from $4.38 billion in 2024 to $4.72 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. This growth during the historical period was supported by factors such as the growing burden of chronic pain, an aging population, increased utilization of opioid-based analgesics, greater public awareness of pain treatment options, and enhanced accessibility to prescription drugs.

The tramadol drug market size is expected to see strong growth in the next few years. It will grow to $6.30 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. Drivers for this forecast period include expanded insurance coverage for pain management therapies, a surge in postoperative interventions, a higher prevalence of orthopedic ailments, a boom in online pharmacy adoption, and greater penetration in developing regions. Key trends expected include innovations in drug delivery technologies, introduction of abuse-deterrent drug formats, use of combination treatments with non-opioid agents, AI-powered drug development, and the implementation of smart packaging for enhanced medication monitoring.

The increasing prevalence of orthopedic disorders is anticipated to drive the growth of the tramadol drug market. Orthopedic disorders refer to medical conditions that impact the bones, joints, muscles, ligaments, or tendons, often resulting in pain and restricted movement. As the aging population continues to grow, the occurrence of age-related conditions such as osteoarthritis and osteoporosis is rising, contributing to joint degeneration and bone weakening. Tramadol proves beneficial for managing orthopedic disorders by alleviating moderate to severe pain associated with fractures, arthritis, or post-surgical recovery. It works by acting on the central nervous system to diminish the perception of pain. For example, in March 2023, a report by the Office for Health Improvement & Disparities, a UK-based government department, revealed that in 2022, 17.6% of individuals aged 16 and above reported having a long-term musculoskeletal (MSK) condition, an increase from 17.0% in 2021. Thus, the rising incidence of orthopedic disorders is contributing to the growth of the tramadol drug market.

The increasing healthcare expenditure is also expected to support the expansion of the tramadol drug market. Healthcare expenditure encompasses the total funds allocated for medical services, treatments, and health-related resources over a specific period. As the population ages, there is a rising demand for healthcare services, long-term care, and age-related treatments, which together exert a heavier financial load on healthcare systems. This growing expenditure underpins the availability and distribution of tramadol by supporting the infrastructure required for its research, regulation, and usage. For instance, in April 2025, the American Medical Association, a U.S.-based professional association, reported that in 2023, health spending in the U.S. increased by 7.5%, totaling $4.9 trillion or $14,570 per person, a notable rise compared to the 4.6% growth in 2022. Therefore, the rising healthcare expenditure is contributing to the expansion of the tramadol drug market.

Leading companies in the tramadol drug market are prioritizing regulatory approvals to broaden their product offerings and enter new regional markets. Regulatory approvals are the formal authorizations issued by governmental health agencies, permitting pharmaceutical firms to legally market and distribute drugs within specific regions. For instance, in July 2022, Kowa Pharmaceuticals America Inc., a U.S.-based pharmaceutical company, announced the publication of Phase 3 clinical trial results for SEGLENTIS, a co-crystal formulation combining celecoxib 56 mg and tramadol hydrochloride 44 mg. Approved by the U.S. Food and Drug Administration, SEGLENTIS is indicated for treating moderate-to-severe acute pain in appropriate adult patients. This multimodal analgesic operates through four complementary mechanisms of pain relief, engaging both peripheral and central pathways, making it a novel alternative for managing acute pain in adults when other treatments prove insufficient.

Major players in the tramadol drug market are Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Limited, Grunenthal GmbH, Nippon Shinyaku Co., Ltd., Ipca Laboratories Ltd., Piramal Pharma Solutions Limited, MSN Laboratories Pvt. Ltd., Ajanta Pharma Limited, Wockhardt Ltd., Troikaa Pharmaceuticals Ltd., Sakar Healthcare Limited, Unosource Pharma Limited, Labopharm Inc., Hiral Laboratories Limited, Nuray Chemicals Pvt. Ltd., Lavybens Pharma Private Limited, Jubilant Generics Limited, SLR Pharma Pvt. Ltd.

North America was the largest region in the tramadol drug market in 2024. The regions covered in tramadol drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tramadol drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tramadol drug market consists of sales of orally disintegrating tablets, oral suspensions, suppositories, topical gels and combination products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tramadol Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tramadol drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for tramadol drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tramadol drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Tramadol Drug Market Characteristics

3. Tramadol Drug Market Trends And Strategies

4. Tramadol Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tramadol Drug Growth Analysis And Strategic Analysis Framework

6. Tramadol Drug Market Segmentation

7. Tramadol Drug Market Regional And Country Analysis

8. Asia-Pacific Tramadol Drug Market

9. China Tramadol Drug Market

10. India Tramadol Drug Market

11. Japan Tramadol Drug Market

12. Australia Tramadol Drug Market

13. Indonesia Tramadol Drug Market

14. South Korea Tramadol Drug Market

15. Western Europe Tramadol Drug Market

16. UK Tramadol Drug Market

17. Germany Tramadol Drug Market

18. France Tramadol Drug Market

19. Italy Tramadol Drug Market

20. Spain Tramadol Drug Market

21. Eastern Europe Tramadol Drug Market

22. Russia Tramadol Drug Market

23. North America Tramadol Drug Market

24. USA Tramadol Drug Market

25. Canada Tramadol Drug Market

26. South America Tramadol Drug Market

27. Brazil Tramadol Drug Market

28. Middle East Tramadol Drug Market

29. Africa Tramadol Drug Market

30. Tramadol Drug Market Competitive Landscape And Company Profiles

31. Tramadol Drug Market Other Major And Innovative Companies

32. Global Tramadol Drug Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tramadol Drug Market

34. Recent Developments In The Tramadol Drug Market

35. Tramadol Drug Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기